Lariatin A
Lariatins is a novel anti-mycobacterial peptides with a lasso structure produced by Rhodococcus jostii K01-B0171[1].
Product Specifications
CAS Number
732286-09-8
UNSPSC
12352209
Target
Bacterial
Type
Peptides
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/lariatin-a.html
Solubility
10 mM in DMSO
Smiles
O=C([C@H]1NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(CNC(CC1)=O)=O)CO)=O)CCC(N)=O)=O)CC(C)C)=O)C(C)C)=O)CC2=CC=C(C=C2)O)=O)CCCNC(N)=N)=O)N[C@H](C(N[C@@H](C(C)C)C(NCC(N[C@H](C(N[C@@H](CO)C(N[C@@H](CC(N)=O)C(N[C@@H](C(C)C)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CCCCN)C(N3[C@@H](CCC3)C(O)=O)=O)=O)=O)=O)=O)=O)CC4=CN=CN4)=O)=O)=O)CC5=CNC6=CC=CC=C56
Molecular Formula
C94H143N27O25
Molecular Weight
2051.31
References & Citations
[1]Iwatsuki M, et al. Lariatins, novel anti-mycobacterial peptides with a lasso structure, produced by Rhodococcus jostii K01-B0171. J Antibiot (Tokyo) . 2007;60 (6) :357-363.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
